• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB CRYSTALSERT INSERTER; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB CRYSTALSERT INSERTER; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Model Number CI-28
Device Problems Insufficient Information (3190); Device Handling Problem (3265)
Patient Problems Eye Injury (1845); No Code Available (3191)
Event Date 10/02/2019
Event Type  Injury  
Manufacturer Narrative
The device has not been returned for evaluation.Investigation of this event is in progress.Upon completion of the investigation, a follow up report will be submitted.
 
Event Description
It was reported that an intraoperative exchange on the left eye took place due to the trailing haptic of the initial intraocular lens (iol) being cut in half by the insertion device during iol implantation.The incision was enlarged almost as wide as the optic in order to remove the iol prior to lens exchange.A suture was placed after the intraoperative lens exchange.In the surgeon's opinion, the likely cause of the event was the insertion device cut off the trailing haptic of the optic.The patient has recovered.
 
Manufacturer Narrative
Additional information: additional visual inspection was completed for this event.The investigation team inspected 3 retain inserters from lot h956901l under 10x-20x magnification.All retain samples showed no presence of particulate or flash in the lens path that could have caused any damage to the lens in the manner described in the event.Based on the results of the visual inspection performed on the lens, the three retain inserters from lot h953502, and the information provided by the account rep, no issues were observed that can confirm the description of the reported event.The results showed that the inserters were assembled for intended use and shipped with no damages and packaged as intended to keep good condition for use.The additional information does not change the investigation findings submitted in the previous report.
 
Manufacturer Narrative
Additional information: the product was not returned for evaluation.The lot history, trend analysis, risk analysis and directions for use review are considered acceptable, with the product performing within anticipated rates.There have been no other complaints for this lot to date.The duovisc viscoelastic used is not validated for use with b&l products, therefore the most probable root cause is "operational context".User related factors (such as loading or handling techniques) and/or procedural factors (such as lens and inserter interaction) might have contributed to the event.No corrective action is necessary at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CRYSTALSERT INSERTER
Type of Device
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman street
rochester NY 14609
MDR Report Key9280010
MDR Text Key174296789
Report Number0001313525-2019-00171
Device Sequence Number1
Product Code MSS
Combination Product (y/n)Y
PMA/PMN Number
K082944
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup,Followup
Report Date 01/01/2005,10/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date05/24/2020
Device Model NumberCI-28
Device Lot NumberH953502
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 10/09/2019
Initial Date FDA Received11/05/2019
Supplement Dates Manufacturer Received11/08/2019
12/03/2019
Supplement Dates FDA Received11/21/2019
12/18/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
DUOVISC VISCOELASTIC, CRYSTALENS AO1UV IOL.
Patient Outcome(s) Required Intervention;
Patient Age72 YR
-
-